Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/6/25 19:30 | 1/2/25 | TERN | Health | Drug | Pharmaceutical Preparations | Kuriakose Emil | CA | O | Chief Me | 1 | S | -26 | 5.71 | 0 | -4 | 54 | D | |||||||||||||||
1/6/25 19:30 | 1/2/25 | TERN | Health | Drug | Pharmaceutical Preparations | Vignola Mark J. | CA | O | CFO | 2 | S.dm | -209 | 7.69 | 0 | -27 | 92 | D | |||||||||||||||
1/6/25 19:30 | 1/2/25 | TERN | Health | Drug | Pharmaceutical Preparations | Quigley Jill M. | CA | D | 4 | S.dm | -520 | 8.39 | 0 | -62 | 30 | D | ||||||||||||||||
7/17/24 20:53 | 7/15/24 | TERN | Health | Drug | Pharmaceutical Preparations | Gordon Carl L | CA | DT | 1 | S.m | -562 | 10.00 | 0 | -56 | 756 | I | ||||||||||||||||
7/17/24 20:48 | 7/15/24 | TERN | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | DT | 1 | S.m | -562 | 10.00 | 0 | -56 | 756 | I | ||||||||||||||||
4/3/24 20:47 | 4/1/24 | TERN | Health | Drug | Pharmaceutical Preparations | Vivo Opportunity, LLC | CA | T | 1 | S.m | -2,797 | 6.65 | 0 | -421 | 6,237 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |